The transition from pre-clinical research to large-scale production while maintaining strict quality standards is challenging in the biopharmaceutical sector. This challenge is made more difficult by the need for expertise in a wide range of areas, including state-of-the-art gene and cell therapies, microbial fermentation, and cell culture. Pharmaceutical companies are competing to stay at the forefront of innovation, therefore now more than ever, they need a trustworthy and experienced CDMO partner.

In this industry, Fujifilm Diosynth Biotechnologies has established itself as a pioneer, especially where precision and innovation meet. The company offers a wide range of solutions, from process development and pre-clinical research to commercial cGMP production. It is a global partner of the Contract Development and Manufacturing Organization (CDMO). For almost three decades, Fujifilm Diosynth Biotechnologies has been a mainstay of the biopharmaceutical industry, continuously advancing the drugs of the future in an effort to become the best-known and most esteemed CDMO in the industry.

Fujifilm With contemporary cGMP manufacturing facilities coupled with technological leadership in cell culture, microbial fermentation, and gene and cell treatments, Diosynth Biotechnologies positions itself as a CDMO partner for life. For more than thirty years, the company has consistently supported clients in the research and production of recombinant proteins, viral vaccines, and gene treatments.

With a strong global network, Fujifilm Diosynth Biotechnologies operates in key locations worldwide, including Cambridge, Massachusetts, USA; College Station, Texas, USA; Hillerød, Denmark; Holly Springs, North Carolina, USA (coming online in 2025); Research Triangle Park, North Carolina, USA; Teesside, United Kingdom; Thousand Oaks, California, USA; Tokyo, Japan (Sales & Customer Support); and Watertown, Massachusetts, USA. This broad reach is indicative of the company’s dedication to offering high-quality, easily accessible biomanufacturing services.

Under the direction of an experienced group of executives, Fujifilm Diosynth Biotechnologies has unmatched leadership. Their different professional experiences and combined knowledge guarantee that the organization stays ahead of industry trends and is in tune with the changing needs of its customers.

Reputably, Fujifilm Diosynth Biotechnologies offers top-notch services for cell line and process development. The company has established itself as a reliable name in cell culture solutions for the biopharmaceutical sector. The company provides a full range of cell culture services, including efficient, high-quality cell lines, scalable production techniques for cGMP production, and early-stage manufacturability studies.

With its high-titer manufacturing procedures for the effective microbial expression of recombinant proteins, the company specializes in microbial fermentation. Their scalable, reliable, and established platform, pAVEwayTM, serves as the cornerstone for commercial cGMP manufacturing. Fujifilm Diosynth Biotechnologies is a reliable partner for the creation of large-scale processes in microbial hosts, such as E. coli, P. pastras, and S. cerevisiae, having over 30 years of experience in this field.

Fujifilm Diosynth Biotechnologies is a global provider of cell and gene therapy services. It runs top-notch cGMP-compliant facilities that guarantee efficient and dependable production. Applying their knowledge, the company contributes significantly to the advancement of viral vaccines, gene and cell therapies, and changes the biopharmaceuticals industry.

With regard to viral vector gene therapy, Fujifilm Diosynth Biotechnologies expands its scope of expertise by providing cGMP manufacturing and process development for cell and gene therapy products, oncolytic viruses, and viral vaccines. The company strengthens the development and production of innovative treatments by utilizing an integrated strategy, thereby solidifying its position as a comprehensive CDMO partner.

Fujifilm Diosynth Biotechnologies is a leader in the development of vaccines, from preclinical research to commercial supply. The company maintains a patient-centric emphasis while offering agile and flexible solutions for clinical to commercial products, all while providing end-to-end services.

The company is a strategic CDMO partner that offers knowledgeable CMC (Chemistry, Manufacturing, and Controls) support services since it understands the complexity of regulatory environments. With over thirty years of experience, lab services, cutting-edge technological platforms, and first-rate facilities under its belt, the company guarantees smooth support at every stage of the development and commercialization process.

With its Science Portal for Kids, Fujifilm Diosynth Biotechnologies dedicates a space for inspiration and education beyond its contributions to the industry. Young brains can discover the realm of science here, where they can interact with superheroes like Charlotte Cho, Victor Virus, Necoli E. coli, and Poppy Protein, each of which has unique abilities to make learning entertaining and educational.

A significant player in the biopharmaceutical industry, Fujifilm Diosynth Biotechnologies personifies the spirit of “Cell Culture Innovators.” Living true to its objective of being the top and most reliable global CDMO partner in the biopharmaceutical industry, the firm continues to influence the future of pharmaceutical manufacturing with a long history of accomplishments, a global footprint, and a dedication to improving medicines.